Circulogene
Healthcare Services · Alabama, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3125 Independence Dr Ste 301, Birmingham...Phone Number
(205) 521-8151Website
www.circulogene.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
3
2
2
3
2
About Circulogene
Circulogene is a Liquid Biopsy Center specializing in best-in-class molecular and genomic tests for comprehensive genomic profiling of solid tumors at all stages. The company offers innovative tests such as LungLifeAI for assessing indeterminate pulmonary nodules and OncoGenDx for precision oncology decisions. With a focus on personalizing and monitoring treatment plans, Circulogene has supported over 25,000 cancer patients, aiming for improved outcomes and survival rates. Their advanced methodologies combine next-generation sequencing and PCR technology to enhance the detection and monitoring of cancer-associated genes.Explore more
Circulogene Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Circulogene your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Circulogene had a recent Job posting/layoffs
Product Launch: Get notified when Circulogene launches new products
Funding: Get notified immidiatlly once Circulogene has new funding data
Circulogene, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Circulogene is spiking on competitors!
Earning: See what the market has to say on Circulogene recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Circulogene
Website visits: Recent activity has been detected on your website
Check if Circulogene has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Circulogene as Masked Content
Find 3 more new buyers
Compare Similar Companies to Circulogene
Compare insights from companies similar to Circulogene, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Circulogene is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Circulogene is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Circulogene.
Circulogene financials insights
Gather financial insights about Circulogene, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Private Equity
$1.2M
2016
Debt
$750K
2020
Debt
$350K
Circulogene Tech Stack
A closer look at the technologies used by Circulogene
See more technologies
Most Recent Scoops
Left Company
Executive Move
Circulogene has announced that Stephen Unger, Chief Financial Officer, has left the organization to join Sannova Analytical as Chief Financial Officer.
New Hire
Executive Move
Funding
Circulogene has received an SBA PPP loan for $350,000 from ServisFirst Bank, supporting the retention of 24 jobs.
Funding
Circulogene News & Media
Circulogene Launches LungLifeAI® Nationally Through Primary Care Channel
PENSACOLA, Fla., June 24, 2025 /PRNewswire/ -- Circulogene, a leading provider of precision diagnostics for lung cancer, has announced the national commercial launch of LungLifeAI®, now available across its expanding base of primary care clients. Circulogene Launches LungLifeAI®...Circulogene Announces Exclusive Commercial Launch of LungLifeAI® for Indeterminate Pulmonary Nodule Assessment
PENSACOLA, Fla., May 13, 2025 /PRNewswire/ -- Circulogene is excited to announce the exclusive commercial launch of LungLifeAI®, a breakthrough AI-driven blood-based test designed to improve clinical decision-making in patients with indeterminate pulmonary nodules (IPNs) detected through...Mako Alliance Welcomes Circulogene and Expands Membership Across Five States
RALEIGH, N.C., March 5, 2024 /PRNewswire/ -- The Mako Alliance, a pioneering network of healthcare and biotechnology organizations dedicated to advancing medical research and patient care, is thrilled to announce the addition of Circulogene, a leading liquid biopsy testing company, to its...Research indicates that positive PD-L1 detected by CIRCULOGENE liquid biopsy can have favorable outcomes for cancer patients
Based on a 3-year, real-world study of patients with metastatic NSCLC, plasma cfRNA PD-L1 expression was as effective as tissue PD-L1 expression for informing ICI treatment benefit, and could identify additional patients who would otherwise be missed by tissue PD-L1 protein testing alone. (PRWeb June 09, 2023) Read the full story at https://www.prweb.com/releases/2023/6/prweb19381464.htm
Read more news
Top Healthcare Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Circulogene
Sign Up For FreeTo access detailed company insights
Circulogene is a Liquid Biopsy Center specializing in best-in-class molecular and genomic tests for comprehensive genomic profiling of solid tumors at all stages. The company offers innovative tests such as LungLifeAI for assessing indeterminate pulmonary nodules and OncoGenDx for precision oncology decisions. With a focus on personalizing and moni... Read More
